Trials / Terminated
TerminatedNCT03113864
Effects of Lutein on Visual Function
Beneficial Effects of Lutein on Visual Function in Healthy Subjects
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Kemin Foods LC · Industry
- Sex
- All
- Age
- 40 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Randomized, double blind, placebo-controlled intervention trial on the ocular benefits and inflammatory markers improvements of taking FloraGLO Lutein for 9 months. The population of interest is middle-aged men and women who have low levels of carotenoids in their eyes.
Detailed description
The participants will be given a brief explanation of the study and asked to sign an informed consent form. During the screening visit, pre-study parameters will be measured in order to assess the subjects' eligibility to participate. These include: 1. Medical History 2. Vital signs, Height and weight and BMI calculation 3. Visual Parameters 4. Blood draw for clinical chemistry and hematological safety Intervention Period: At baseline visual parameters and a serum sample for analysis of inflammatory markers will be taken. Supplements will be dispensed. Study visits will then be conducted every 3 months. At these visits, subjects will have visual parameters, adverse events, study diary, vitals, a questionnaire evaluating health/diet/exercise/alcohol, product distribution and compliance checked. A final serum/plasma sample will be taken at the final visit for re-assessment of safety parameters and inflammatory markers. Compliance check: The number of tablets dispensed at baseline and returned, as well as all intake information from a subject diary. Per protocol population is defined apriori as \>80%.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | Daily supplementation for 9 months |
| DIETARY_SUPPLEMENT | Lutein | Daily Supplementation for 9 months |
Timeline
- Start date
- 2017-04-15
- Primary completion
- 2018-06-30
- Completion
- 2018-06-30
- First posted
- 2017-04-14
- Last updated
- 2018-12-06
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03113864. Inclusion in this directory is not an endorsement.